Neuromuscular disorders

Slides:



Advertisements
Similar presentations
Neurological Diseases Jerry Carley RN, MSN, MA, CNE
Advertisements

FACULTY OF MEDICINE PHYSIOLOGY DEPARTMENT DR. NERMEN MADY DR. RAMEZ.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Myasthenia Gravis Dr. Belal M. Hijji, RN. PhD February 29, 2012.
Muscle weakness Index case Year 1 Michaelmas Term.
Guillain-Barré Syndrome, Myasthenia Gravis,
Terri Kueber, CRNA, MS. Explain the pathophysiology and classification of Myasthenia Gravis (MG) List the signs and symptoms and clinical manifestation.
The skeletal muscles can be affected by diseases affecting the muscle primarily as myositis or muscular dystrophies or secondarily due to systemic abnormality.
Skeletal muscle system disease Prepared by: Siti Norhaiza Binti Hadzir.
NEUROMUSCULAR JUNCTION
Synaptic transmission *** Synapse is the junction between two neurones where electrical activity of one neurone is transmitted to the other.
NEUROMUSCULAR JUNCTION DR. ZAHOOR ALI SHAIKH LECTURE
Nuha Alkhawajah MD.   Disorders affecting the junction between the presynaptic nerve terminal and the postsynaptic muscle membrane  Pure motor syndromes.
Agents Used to Treat Musculoskeletal Health Alterations.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
 Myasthenia gravis is a chronic autoimmune neuromuscular disease that is characterized by different degrees of weakness of the skeletal muscles of the.
1 Review of Musculoskeletal System Chapter Muscle Skeletal muscle > 600 muscles in body Fascia –Epimysium – forms tendons at ends –Perimysium –
NEUROMUSCULAR JUNCTION BLOCKERS BY :DR ISRAA OMAR.
Anaesthesia in myasthenia Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics, PhD (physio) Mahatma Gandhi Medical college.
GENERAL THORACIC SURGERY CHAPTER 168
Botulism Presentation Gabriela Pontes de Sousa. Botulism Latin: botulus = sausage Is a rare but serious paralytic illness caused by botulinum toxin, which.
Myasthenia Gravis 重症肌无力(MG)
Myasthenia Gravis.  Describe myasthenia gravis  Signs and Symptoms of the disease  Describe the treatments available Purpose and Objectives.
Floppy Adolescent Joshua Rocker, MD Schneider Children’s Hospital Long Island Jewish Medical Center.
MYASTHENIA GRAVIS (MG)
Sophia M. Chung, M.D. Depts of Ophthalmology &
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Myasthenia Gravis Victor Politi,M.D.
MYASTHENIA GRAVIS ANESTHESIOLOGY Jasdeep Dhaliwal Clinical Rotation.
Pathophysiology, Diagnosis and Medical Management of Myasthenia Gravis
BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.
NEUROMUSCULAR JUNCTION BLOCKERS
Spinal Control of Movement
Myasthenia Gravis.
Disorders of the Neuromuscular Junction
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Myasthenia Gravis.
Neurology Chapter of IAP
NEUROPATHY Subsection B3 Francisco – Go, Kerby + Laxamana September 16, 2009.
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
F.Ahmadabadi MD Child Neurologist July 2015 ARUMS Guillain-Barre syndrome & Myasthenia Gravis.
MYASTHENIA GRAVIS “FROM WEAKNESS SHALL COME STRENGTH”. BY PATTI HAMILTON.
Assessment and Treatments  History: weakness caused by any precipitating factors ( i.e. infection, emotional upset)  Time of weakness: after repeated.
Approach to the Patient with Weakness. What are clinical features that might lead you to believe that weakness is peripheral? Why is it important to localize.
Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.
Nursing management of Myasthenia Gravis
Myasthenia Gravis.
Jennifer Vilarino Period: 5
Myasthenia Gravis.
Neuromuscular junction
Muscular Disorders and Diseases
Motor neuron disease.
Manage a Neurological Mystery
Dysthyroid eye disease
Myasthenia Gravis.
Tetanus neonatorum.
Myasthenia gravis By: Nikki Young.
CHOLINESTERASES ANTICHOLINESTERASES PROPERTIES AND USES
163-1 Myasthenia/Thymoma.
Junctions & Synapses Lec 5.
School of Pharmacy, University of Nizwa
“Grave Muscle Weakness”
School of Pharmacy, University of Nizwa
The Muscular System.
Skeletal Muscle Pathology For Second Year Dental Students
Chapter 6 Muscarinic [,mʌskə‘rinik]毒蕈碱的 receptor agonists
Chapter 7 Excitation of Skeletal Muscle
Lambert-Eaton Myasthenic Syndrome (LEMS)
Presentation transcript:

Neuromuscular disorders Myasthenia gravis Eaton Lambert syndrome Botulism

MYASTHENIA GRAVIS AUTOIMMUNE DISORDER ANTIBODIES DIRECTED TOWRDS THE ACETYLCHOLINE RECPTORS AT POST SYNAPTIC MEMBRANE AFFECTS ANY AGE BUT MAINLY AGE 20-30 YEARS 2 FEMALE >1 MALE ROLE OF THYMUS

Role of the thymus Abnormalities of the thymus in 80 % Production of T-cell lymphocytes which participate in the immune responses

Pathophysiology III-postsynpatic membrane:Ach receptors Neuromuscular junction is composed of I-Presynaptic nerve ending which contains the synaptic vesicles(Ach) II.Synaptic cleft III-postsynpatic membrane:Ach receptors Reuptake of the Ach by choline-estetrase

Clinical features I Fatigability

DEFINITION FAILURE TO SUSTAIN A MAINTAINED OR REPEATED CONTRACTION OF STRIATED MUSCLES

Clinical features II Onset usually insidious Fluctuating weakness Weakness at the end of the day Extraocular muscles (ptosis) Bulbar muscles Limbs generalized

Clinical features III Onset can be fulminant With involvement of respiratory muscles Weakness may be provoked by : Infection, hypo k., hypocalcemia Drugs : Quinine.betablockers,phenytoin Sedatives (diazepam) Antibiotics Surgery,pregnancy

Clinical exam I Look for fatigability Examine motor power :first movement is normal Repeat movements; weakness will appear All muscles should be examined Induce fatigue (no change of power in normal individual)

Clinical exam II Every thing else is normal Reflexes unaffected No wasting No deformity Tone is normal No sensory change

Clinical exam III May be associated with diseases Malignancy Autoimmune disorders. Then look for associated features

Test to be used in the clinic :Tensilon test Technique: Inject edrophonium (10 mg in 1cc) First 2 mg (0.2 cc) If no hypotension or hypersensitivity Inject the rest (8mg) Result: Weakness improves within 1-2 minutes

CRISiS I- Myasthenic crisis II-Cholinergic crisis

I.Myasthenic Crisis Precipitating factors Infections Changes of drugs Pregnancy Surgery

II-cholinergic crisis Excessive use of anticholinergic medication Myosis,diarrhea, increased salivation Abdominal cramps bradycardia

Investigations I Logical (immune disorder) Look for antibodies in serum EMG Repetetive stimulation test Technique : Exert repetetive stimulation o nerve (ulnar) at 3,10,30-50 (tetanization) and look for response -> decremential response Single fiber EMG :increased jitter.=delayed NMJ transmision

Investigations II Biopsy of the neuromuscular joint And electron microscope study Severe Loss of receptors Look for the thymus by CXR,CT,MRI

Neonatal MG 12-16 % of infant born to myasthenic mother have myasthenic features (ptosis,weakness,poor cry and suck) Last up to 6 weeks Due to transplacental transfer of maternal circulating anti-Ach receptor antibodies Temporary administration of anti choline esterase agents may be needed

Treatment I 1-Anticholine esterase agents A-Short acting :neostigmine (Prostigmine) B-Long acting : pyridostigmine (Mestinon) 20.60 and 180 mg 2-4 times a day SE : increased bronchial secretions bronchspasm,miosis,diarrhea,abdominal cramps,bradycardia

Treatment II Reduce circulating antibodies Plasmpheresis

Treatment III :immunemodulation Steroids Immunosupressants IVIG

Treatment VI Thymus Thymectomy Thymic hyperplasia ? More common :70%

EATON LAMBERT SYNDROME I Male > female Later onset Associated with oat cell carcinoma of the lung in 70% Affects mainly lower extremities Clinically initial fatigability-weakness which improves on continuing the effort Due to impairment of the Ach release in the presynaptic part

E-L syndrome II Neurophysilogy:incremental response Treat the underlying cause

Botulism Bacterial :clostridium botilinum an anaerobic spore forming bacteria -> very strong toxin May be present in improperly canned food In raw meat Toxin impairs pre-synaptic Ach release Leads to severe weakness and autonomic features

Botulism Supportive treatment Tracheostomy Death in about 15 % Botulinum toxin (Botox) is used in dystonia, spasticity and for cosmetic purposes